FMR Global Research

Case Study

U&A PRF Real Data – Post Launch Study

Objective of the Study

After launching a new product for OA pain in March 2021, the client wanted to understand usage behaviors, frequency and volumes via access to real patient profiles / patient cases.

Methodology

GEOGRAPHICAL SCOPE

UK, Germany, France, Italy, Spain

METHODOLOGY

Mix-mode: Web interviews optimized with phone recruitment.

Each respondent provided 5-7 patient record forms

1,932 patient record forms collected in total

SAMPLE

375 Veterinarians (75 per country)

TARGET DETAILS

Companion Animal GP Vets treating OA pain in dogs

LOI = 40-45 minutes

MAIN RESULTS

This project provided key insight into:

Main reasons to start treatment with the new product

Comorbidities or associated conditions when starting the OA therapy

Triggers for OA diagnosis or suspicion

Compliance rate with monthly dosing

Treatment algorithm: previous treatments, reasons to switch, treatment combinations, number of doses, follow-up frequency, satisfaction rate with the new product

Relevant patient profiles: according to previous treatment, which patients are the biggest potential for Brand X and where positioning needs to be improved 

KEY TAKE-AWAY

Arguments to be provided to Veterinarians to motivate them to continue using Brand X (for the ones who are using it already) or start using Brand X (using real data from Vets who are satisfied with the product’s results)

Satisfaction rates across all severity stages (mild-moderate-severe OA)

No other treatment needed since starting Brand X

FMR Global Health is the health research arm of FMR Global Research

X